Published in Vaccine Weekly, March 3rd, 1997
The vaccine consists of inactivated M. vaccae administered in three intradermal inoculations at two-month intervals.
C.F. Von Reyn and B.J. March of Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, presented data from the studies at the Fourth Conference on Retroviruses and Opportunistic Infections, held January 22-26, 1997, in Washington, D.C.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly